Link Pharma Chem

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE302F01011
  • NSEID:
  • BSEID: 524748
INR
29.05
-0.59 (-1.99%)
BSENSE

Feb 12

BSE+NSE Vol: 221

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 376687,
    "name": "Link Pharma Chem",
    "stock_name": "Link Pharma Chem",
    "full_name": "Link Pharma Chem Ltd",
    "name_url": "stocks-analysis/link-pharma-chem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.05",
    "chg": -0.59,
    "chgp": "-1.99%",
    "dir": -1,
    "prev_price": "29.64",
    "mcapval": "13.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524748,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE302F01011",
    "curr_date": "Feb 12",
    "curr_time": "",
    "bse_nse_vol": "221 ",
    "exc_status": "Active",
    "traded_date": "Feb 12, 2026",
    "traded_date_str": "2026 02 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/link-pharma-chem-376687-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Link Pharma Chem Ltd Falls to 52-Week Low of Rs.28 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-falls-to-52-week-low-of-rs28-amidst-continued-downtrend-3787337",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LinkPharmaChemL_priceRelatedfactors_3787337.png",
        "date": "2026-01-09 15:40:42",
        "description": "Link Pharma Chem Ltd has touched a fresh 52-week low of Rs.28 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has underperformed its sector and benchmark indices, reflecting persistent pressures on its financial performance and valuation metrics."
      },
      {
        "title": "Link Pharma Chem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/link-pharma-chem-ltd-is-rated-strong-sell-3771086",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LinkPharmaChemL_mojoScore_3771086.png",
        "date": "2025-12-26 15:12:32",
        "description": "Link Pharma Chem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Why is Link Pharma Chem falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-link-pharma-chem-fallingrising-3764304",
        "imagepath": "",
        "date": "2025-12-20 02:23:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Intraday Performance and Market Reaction</strong></p>\n<p>Link Pharma Chem's shares opened with a substantial gap up of 11.97%, signalling strong buying interest from the outset of trading on 19 December. The stock reached an intraday high of ₹33.59, reflecting a robust upward momentum throughout the session. This surge contrasts with the broader market trend, as the Sensex remained relatively flat with a marginal decline of 0.40% over the past week, underscoring the stock's relative strength.</p>\n<p>The stock's performance today also outpaced its sector by 8.21%, highlighting a clear divergence from sectoral trends and suggesting company-specific factors or renewed investor confidence driving the rally. This rebound follows a brief period of weakness, with the stock recovering after two days..."
      },
      {
        "title": "Link Pharma Chem Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/link-pharma-chem-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3755187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LinkPharmaChem_mojoScore_3755187.png",
        "date": "2025-12-10 10:10:18",
        "description": "Link Pharma Chem has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The reassessment highlights concerns across quality, valuation, financial trends, and technical indicators, underscoring the pressures faced by this microcap player in the commodity chemicals sector."
      }
    ],
    "total": 81,
    "sid": "376687",
    "stock_news_url": "https://www.marketsmojo.com/news/link-pharma-chem-376687"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For The Quarter And Nine Months Period Ended On 31St December 2025",
      "datetime": "07-Feb-2026",
      "details": "Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Link Pharma chem Ltd has informed BSE that the meeting of Board of Directors of company is scheduled on 14/02/2026 inter-alia to consider and approve Unaudited financial results for Quarter and nine months period ended on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "28-Jan-2026",
      "details": "Disclosure order Regulation 30 read with Part A of Schedule III of SEBI Regulation 2015 Demand order from Assistant Commissioner Central GST & Central Excise Vadodara FY 2021-22",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "We are enclosed herewith the confirmation Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for quarter ended December 31 2025 received from M/s. MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited) RTA of the company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For The Quarter And Nine Months Period Ended On 31St December 2025

07-Feb-2026 | Source : BSE

Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Link Pharma chem Ltd has informed BSE that the meeting of Board of Directors of company is scheduled on 14/02/2026 inter-alia to consider and approve Unaudited financial results for Quarter and nine months period ended on 31st December 2025.

Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

28-Jan-2026 | Source : BSE

Disclosure order Regulation 30 read with Part A of Schedule III of SEBI Regulation 2015 Demand order from Assistant Commissioner Central GST & Central Excise Vadodara FY 2021-22

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

12-Jan-2026 | Source : BSE

We are enclosed herewith the confirmation Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for quarter ended December 31 2025 received from M/s. MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited) RTA of the company.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

14 Feb 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available